Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berenbaum

Showing results (81-90 of 984) with videos related to

Pageof 99
Sort By:
Hospital Practice (Office Ed.)|January 30, 1985
Unmasking clinical depressionI L Berenbaum
Clinical and Experimental Immunology|January 1, 1971
Is azathioprine a better immunosuppressive than 6-mercaptopurine?M C Berenbaum
Cancer Chemotherapy Reports|October 1, 1972
In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agentsM C Berenbaum
Proceedings of the Royal Society of Medicine|March 1, 1972
Immunosuppressive agents: generation and consequences of differing dose-response curvesM C Berenbaum
Journal of Agricultural and Food Chemistry|April 18, 2015
Does the Honey Bee "Risk Cup" Runneth Over? Estimating Aggregate Exposures for Assessing Pesticide Risks to Honey Bees in AgroecosystemsMay R Berenbaum
Clinical and Experimental Immunology|April 1, 1977
Synergy, additivism and antagonism in immunosuppression. A critical reviewM C Berenbaum
Pharmacological Reviews|June 1, 1989
What is synergy?M C Berenbaum
The British Journal of Radiology|October 1, 1988
Antagonism between radiosensitizing agentsM C Berenbaum
Lancet (London, England)|April 5, 1980
Research ethics and deceptionM C Berenbaum
The Journal of Antimicrobial Chemotherapy|April 1, 1988
Synergy and antagonism are not synonymous with therapeutic advantage and disadvantageM C Berenbaum
Pageof 99

Showing results (81-90 of 984) with videos related to

Sort By:
Pageof 99
Hospital Practice (Office Ed.)|January 30, 1985
Unmasking clinical depressionI L Berenbaum
Clinical and Experimental Immunology|January 1, 1971
Is azathioprine a better immunosuppressive than 6-mercaptopurine?M C Berenbaum
Cancer Chemotherapy Reports|October 1, 1972
In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agentsM C Berenbaum
Proceedings of the Royal Society of Medicine|March 1, 1972
Immunosuppressive agents: generation and consequences of differing dose-response curvesM C Berenbaum
Journal of Agricultural and Food Chemistry|April 18, 2015
Does the Honey Bee "Risk Cup" Runneth Over? Estimating Aggregate Exposures for Assessing Pesticide Risks to Honey Bees in AgroecosystemsMay R Berenbaum
Clinical and Experimental Immunology|April 1, 1977
Synergy, additivism and antagonism in immunosuppression. A critical reviewM C Berenbaum
Pharmacological Reviews|June 1, 1989
What is synergy?M C Berenbaum
The British Journal of Radiology|October 1, 1988
Antagonism between radiosensitizing agentsM C Berenbaum
Lancet (London, England)|April 5, 1980
Research ethics and deceptionM C Berenbaum
The Journal of Antimicrobial Chemotherapy|April 1, 1988
Synergy and antagonism are not synonymous with therapeutic advantage and disadvantageM C Berenbaum
Pageof 99